BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 1754517)

  • 1. Growth hormone receptor expression in the Dunning R 3327 prostatic carcinoma of the rat.
    Sinowatz F; Breipohl W; Waters MI; Lincoln D; Lobie PE; Amselgruber W
    Prostate; 1991; 19(4):273-8. PubMed ID: 1754517
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Growth hormone and colorectal carcinoma: localization of receptors.
    Lincoln DT; Kaiser HE; Raju GP; Waters MJ
    In Vivo; 2000; 14(1):41-9. PubMed ID: 10757060
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Up-regulation of growth hormone receptor immunoreactivity in human melanoma.
    Lincoln DT; Sinowatz F; Kölle S; Takahashi H; Parsons P; Waters M
    Anticancer Res; 1999; 19(3A):1919-31. PubMed ID: 10470136
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Growth hormone in vascular pathology: neovascularization and expression of receptors is associated with cellular proliferation.
    Lincoln DT; Singal PK; Al-Banaw A
    Anticancer Res; 2007; 27(6B):4201-18. PubMed ID: 18225592
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Murine monoclonal antibodies reactive with a variety of androgen independent Dunning rat prostate adenocarcinoma sublines also reactive with human prostate adenocarcinoma.
    Tjota A; Lee MT; Isaacs JT; Kadohama N; Lee CL
    J Urol; 1991 Jul; 146(1):205-12. PubMed ID: 2056591
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Localization of the growth hormone receptor/binding protein in skin.
    Lobie PE; Breipohl W; Lincoln DT; García-Aragón J; Waters MJ
    J Endocrinol; 1990 Sep; 126(3):467-71. PubMed ID: 2212936
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cellular localization of the growth hormone receptor/binding protein in the male and female reproductive systems.
    Lobie PE; Breipohl W; Aragón JG; Waters MJ
    Endocrinology; 1990 Apr; 126(4):2214-21. PubMed ID: 2156686
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary Ki-1 lymphoma of the skin: expression of growth hormone receptors.
    Lincoln DT; Temmin L; al-Jarallah MA; Mathew TC; Dashti H
    Nutrition; 1995; 11(5 Suppl):627-31. PubMed ID: 8748238
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of mesenchyme of the embryonic urogenital sinus and neonatal seminal vesicle on the cytodifferentiation of the Dunning tumor: ultrastructural study.
    Wong YC; Cunha GR; Hayashi N
    Acta Anat (Basel); 1992; 143(2):139-50. PubMed ID: 1598820
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Growth hormone receptor expression in the nucleus and cytoplasm of normal and neoplastic cells.
    Lincoln DT; Sinowatz F; Temmim-Baker L; Baker HI; Kölle S; Waters MJ
    Histochem Cell Biol; 1998 Feb; 109(2):141-59. PubMed ID: 9504775
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cellular localization of the growth hormone binding protein in the rat.
    Lobie PE; García-Aragón J; Wang BS; Baumbach WR; Waters MJ
    Endocrinology; 1992 May; 130(5):3057-65. PubMed ID: 1374020
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential effects of prolactin on rat dorsolateral prostate and R3327 prostatic tumor sublines.
    Johnson MP; Thompson SA; Lubaroff DM
    J Urol; 1985 Jun; 133(6):1112-20. PubMed ID: 4039764
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Basal cells of H-Dunning tumor are myoepithelial cells. A comparative immunohistochemical and ultrastructural study with male accessory sex glands and mammary gland.
    Aumüller G; Gröschel-Stewart U; Altmannsberger M; Mannherz HG; Steinhoff M
    Histochemistry; 1991; 95(4):341-9. PubMed ID: 2022486
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of growth hormone receptor in human prostatic carcinoma and hyperplasia.
    Kölle S; Sinowatz F; Boie G; Temmim-Baker L; Lincoln D
    Int J Oncol; 1999 May; 14(5):911-6. PubMed ID: 10200341
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dose/response study of the effects of oestrogens on tumour growth and morphology in the Dunning R3327 prostatic adenocarcinoma.
    Landström M; Damber JE; Bergh A; Tomic R
    J Cancer Res Clin Oncol; 1992; 118(1):30-4. PubMed ID: 1729258
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiestrogens do not counteract the inhibitory effect of estradiol-17 beta on the growth of the Dunning R3327 prostatic adenocarcinoma.
    Landström M; Damber JE; Bergh A; Tomic R; Carlsson-Bostedt L; Stigbrand T
    Prostate; 1988; 12(4):287-98. PubMed ID: 3393491
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The epithelial origin of a stromal cell population in adenocarcinoma of the rat prostate.
    Beckman WC; Camps JL; Weissman RM; Kaufman SL; Sanofsky SJ; Reddick RL; Siegal GP
    Am J Pathol; 1987 Sep; 128(3):555-65. PubMed ID: 2443013
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Castration induces apoptosis in the ventral prostate but not in an androgen-sensitive prostatic adenocarcinoma in the rat.
    Brändström A; Westin P; Bergh A; Cajander S; Damber JE
    Cancer Res; 1994 Jul; 54(13):3594-601. PubMed ID: 8012987
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Growth hormone (GH) receptors in prostate cancer: gene expression in human tissues and cell lines and characterization, GH signaling and androgen receptor regulation in LNCaP cells.
    Weiss-Messer E; Merom O; Adi A; Karry R; Bidosee M; Ber R; Kaploun A; Stein A; Barkey RJ
    Mol Cell Endocrinol; 2004 May; 220(1-2):109-23. PubMed ID: 15196705
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of endogenous receptors for neoglycoproteins in Dunning R3327 rat prostatic carcinoma.
    Sinowatz F; Gabius HJ; Hellmann KP; Amselgruber W; Schneider MR
    Prostate; 1990; 16(2):173-84. PubMed ID: 2320506
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.